Medical Weight Loss Treatments

GLP-1 weight loss is in high demand—and medically complex enough to require thorough consent. This GLP-1 weight management informed consent for semaglutide and tirzepatide explains how these medications regulate appetite, slow digestion and improve glucose control, then discloses GI, neurological...

Fat-burner injections face heightened scrutiny and require honest, documented consent. This lipotropic injection informed consent explains how vitamin, amino-acid and nutrient compounds are used to support metabolism and fat processing, and clearly states they are not FDA-approved for weight loss...

An off-label weight-loss program carries heightened legal and medical risk that demands full disclosure. This HCG weight loss program informed consent clearly states that hCG is not FDA-approved for weight loss and that its use here is off-label, helping to help ensure patients understand before ...